Skip to content

ResMed RMD Ratios & Valuation

TTM Q3 '26TTM Q2 '26TTM Q1 '26TTM Q4 '25TTM Q3 '25
Profitability
Gross margin241.9%+2.8pp239.1%+2.5pp236.6%+2.4pp234.2%+2.7pp231.5%+3.0pp
Operating margin133.8%+2.1pp131.7%+2.0pp129.7%+3.7pp126%+4.6pp121.4%+5.6pp
Net margin109.5%+1.3pp108.2%+2.2pp106.1%+4.2pp101.9%+5.4pp96.4%+5.2pp
Returns
Return on equity102.2%-0.6pp102.8%0.0pp102.7%+1.8pp100.9%+3.2pp97.7%+3.4pp
Return on invested capital102.6%+2.2pp100.4%+3.1pp97.3%+4.6pp92.7%+5.9pp86.8%+6.5pp
Efficiency
Asset turnover2.7×0.0×2.7×0.0×2.8×0.0×2.8×0.0×2.8×0.0×
Liquidity
Current ratio12.4×-0.4×12.8×-0.3×13.1×0.0×13.1×+0.9×12.3×+0.4×
Leverage
Debt-to-equity0.7×0.0×0.7×0.0×0.6×0.0×0.6×0.0×0.7×-0.1×
Net debt / EBITDA-0.7×-0.2×-0.5×-0.3×-0.2×-0.4×0.2×-0.6×0.8×-0.7×
Per Share
Book value per share$169.91+4.2%$163.03+4.9%$155.46+4.3%$148.99+5.3%$141.45+4.6%
Valuation
Market capitalization$145.46B-0.1%$145.64B+1.1%$144.05B+3.0%$139.84B+7.2%$130.44B+3.0%
Price / earnings99.8×-3.5×103.4×-3.2×106.6×-4.4×110.9×-0.8×111.7×-5.3×
Price / sales27.3×-0.6×28×-0.3×28.3×+0.2×28.1×+1.3×26.8×+0.2×
Price / book23.4×-0.9×24.3×-0.8×25.2×-0.4×25.5×+0.5×25×-0.4×
EV / EBITDA72.6×-3.1×75.7×-2.3×78×-2.3×80.3×+0.5×79.8×-3.2×
Dividend yield3.6%+0.1pp3.5%+0.1pp3.4%0.0pp3.4%-0.2pp3.6%0.0pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are ResMed's profit margins?
ResMed (RMD) runs a 61.6% gross margin and a 34.2% operating margin, with a 27.4% net margin.
Where do ResMed's ratios come from?
Every ratio is computed from ResMed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.